- Home
- RGC vs TTMI Comparison
RGC vs TTMI Comparison
Compare RGC & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGC | TTMI |
|---|---|---|
| Founded | 2014 | 1978 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 10.8B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RGC | TTMI |
|---|---|---|
| Price | $25.30 | $104.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $98.50 |
| AVG Volume (30 Days) | 106.1K | ★ 1.9M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 211.11 |
| EPS | N/A | ★ 1.68 |
| Revenue | N/A | ★ $2,906,345,000.00 |
| Revenue This Year | N/A | $19.50 |
| Revenue Next Year | N/A | $17.68 |
| P/E Ratio | ★ N/A | $62.87 |
| Revenue Growth | N/A | ★ 18.98 |
| 52 Week Low | $3.99 | $16.55 |
| 52 Week High | $950.00 | $113.46 |
Technical Indicators
Market Signals| Indicator | RGC | TTMI |
|---|---|---|
| Relative Strength Index (RSI) | 43.09 | 55.51 |
| Support Level | $11.83 | $87.28 |
| Resistance Level | $26.42 | $110.38 |
| Average True Range (ATR) | 2.42 | 6.63 |
| MACD | -0.55 | -0.23 |
| Stochastic Oscillator | 15.00 | 65.37 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology products, including mission systems, RF components, RF/microwave assemblies, and advanced interconnect products such as PCBs and substrates. It operates through three segments: A&D, Commercial, and RF&S Components. The A&D segment supports aerospace and defense missions with PCBs, assemblies, microelectronics, and integrated systems. The Commercial segment, generating the majority of revenue, serves automotive, medical, industrial, and data center markets. The RF&S Components segment provides TTM-designed RF components and COTS products. The Company's revenues come from PCBs, engineered systems, and long-term contracts for intelligence, surveillance, and communications solutions.